{"id":"https://openalex.org/W2010078419","doi":"https://doi.org/10.1016/s0740-5472(96)00154-7","title":"A controlled trial of imipramine for the treatment of methamphetamine dependence","display_name":"A controlled trial of imipramine for the treatment of methamphetamine dependence","alternate_titles":[],"publication_year":1996,"publication_date":"1996-11-01","ids":{"openalex":"https://openalex.org/W2010078419","doi":"https://doi.org/10.1016/s0740-5472(96)00154-7","mag":"2010078419","pmid":"https://pubmed.ncbi.nlm.nih.gov/9219147"},"language":"en","primary_location":{"id":"doi:10.1016/s0740-5472(96)00154-7","doi":"https://doi.org/10.1016/s0740-5472(96)00154-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0740-5472(96)00154-7","pdf_url":null,"source":{"id":"https://openalex.org/S82881359","display_name":"Journal of Substance Abuse Treatment","issn_l":"0740-5472","issn":["0740-5472","1873-6483"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Substance Abuse Treatment","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2010078419"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109083060","display_name":"Gantt P. Galloway","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Gantt P. Galloway","raw_affiliation_strings":["Drug Detoxification, Rehabilitation, and Aftercare Program, Haight Ashbury Free Clinics, Inc., San Francisco, CA, USA","New Leaf Treatment Center, Walnut Creek, CA, USA","University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Detoxification, Rehabilitation, and Aftercare Program, Haight Ashbury Free Clinics, Inc., San Francisco, CA, USA","institution_ids":[]},{"raw_affiliation_string":"New Leaf Treatment Center, Walnut Creek, CA, USA","institution_ids":[]},{"raw_affiliation_string":"University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081656867","display_name":"John A. Newmeyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Newmeyer","raw_affiliation_strings":["Drug Detoxification, Rehabilitation, and Aftercare Program, Haight Ashbury Free Clinics, Inc., San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Detoxification, Rehabilitation, and Aftercare Program, Haight Ashbury Free Clinics, Inc., San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110444165","display_name":"Ted Knapp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ted Knapp","raw_affiliation_strings":["Drug Detoxification, Rehabilitation, and Aftercare Program, Haight Ashbury Free Clinics, Inc., San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Detoxification, Rehabilitation, and Aftercare Program, Haight Ashbury Free Clinics, Inc., San Francisco, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111680069","display_name":"S. Alex Stalcup","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S.Alex Stalcup","raw_affiliation_strings":["New Leaf Treatment Center, Walnut Creek, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New Leaf Treatment Center, Walnut Creek, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079646930","display_name":"David Eugene Smith","orcid":"https://orcid.org/0000-0002-6301-7737","observed_orcids":["https://orcid.org/0000-0002-6301-7737"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Smith","raw_affiliation_strings":["University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5109083060"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":{"value":3340,"currency":"USD","value_usd":3340},"apc_paid":null,"fwci":0.2508,"has_fulltext":false,"cited_by_count":78,"citation_normalized_percentile":{"value":0.48489334,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"13","issue":"6","first_page":"493","last_page":"497"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/methamphetamine-dependence","display_name":"methamphetamine dependence","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.8679999709129333},{"id":"https://openalex.org/keywords/drug-addiction-treatment","display_name":"drug addiction treatment","score":0.6819999814033508},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.949999988079071},{"id":"https://openalex.org/keywords/drug-detoxification","display_name":"drug detoxification","score":0.640999972820282},{"id":"https://openalex.org/keywords/craving","display_name":"craving","score":0.5989999771118164},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7059999704360962},{"id":"https://openalex.org/keywords/urine-drug-testing","display_name":"urine drug testing","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.9306848049163818},{"id":"https://openalex.org/C2780376393","wikidata":"https://www.wikidata.org/wiki/Q191924","display_name":"Methamphetamine","level":2,"score":0.814369797706604},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5867242813110352},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5372239351272583},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5101711750030518},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4750792384147644},{"id":"https://openalex.org/C2779541405","wikidata":"https://www.wikidata.org/wiki/Q498902","display_name":"Craving","level":3,"score":0.44415199756622314},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.44249626994132996},{"id":"https://openalex.org/C2779796075","wikidata":"https://www.wikidata.org/wiki/Q3743188","display_name":"Cocaine dependence","level":3,"score":0.44208836555480957},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.4379117786884308},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.36340415477752686},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3625849783420563},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3324149549007416},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.24672755599021912},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000929","descriptor_name":"Antidepressive Agents, Tricyclic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005240","descriptor_name":"Feasibility Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006679","descriptor_name":"HIV Seropositivity","qualifier_ui":"Q000635","qualifier_name":"transmission","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012495","descriptor_name":"San Francisco","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015813","descriptor_name":"Substance Abuse Detection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015819","descriptor_name":"Substance Abuse, Intravenous","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0740-5472(96)00154-7","doi":"https://doi.org/10.1016/s0740-5472(96)00154-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0740-5472(96)00154-7","pdf_url":null,"source":{"id":"https://openalex.org/S82881359","display_name":"Journal of Substance Abuse Treatment","issn_l":"0740-5472","issn":["0740-5472","1873-6483"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","erih-plus","jufo-1","ki-jl-1","norway-1","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Substance Abuse Treatment","raw_type":"journal-article"},{"id":"pmid:9219147","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9219147","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of substance abuse treatment","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G5106517895","display_name":"A CLINICAL/BEHAVIORAL PROGRAM TO FIGHT HIV IN DRUG USERS","funder_award_id":"R18DA006145","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W66173673","https://openalex.org/W363294009","https://openalex.org/W624665717","https://openalex.org/W1475474724","https://openalex.org/W1500141502","https://openalex.org/W1649672895","https://openalex.org/W1964924155","https://openalex.org/W2012008035","https://openalex.org/W2020268637","https://openalex.org/W2055781174","https://openalex.org/W2067495470","https://openalex.org/W2072167486","https://openalex.org/W2095248609","https://openalex.org/W2401101968","https://openalex.org/W2409309548","https://openalex.org/W2415741990","https://openalex.org/W2487664775","https://openalex.org/W4299434359"],"related_works":["https://openalex.org/W2072167486","https://openalex.org/W2061505471","https://openalex.org/W2029272783","https://openalex.org/W2114469645","https://openalex.org/W2228727390","https://openalex.org/W2072691246","https://openalex.org/W2120912266","https://openalex.org/W3119114014","https://openalex.org/W4416315121","https://openalex.org/W1581899689"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2010078419","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
